Emirates Health Services Unveils Pioneering Family Health Initiatives at Arab Health 2025
Dubai: Emirates Health Services (EHS) is participating in the 50th edition of Arab Health 2025, held at the Dubai World Trade Centre, under the theme “Future Health Now”. EHS, as the exclusive health services partner, is showcasing 19 innovative projects, 13 of which are being unveiled for the first time on regional and global levels.
According to Emirates News Agency, EHS has dedicated a special focus area titled “Family Health and Community Care,” highlighting three innovative projects. Two of these projects are making their debut regionally and globally in collaboration with key international partners. Dr. Essam Al Zarooni, Acting Executive Director of the Medical Services Sector at EHS, emphasized the importance of family health as a cornerstone of Emirati society and a top priority in the nation’s strategic plans.
Dr. Al Zarooni stated that these pioneering projects are aimed at providing families with access to advanced healthcare services to ensure a better quality of life. He further mentioned that EHS’s participation in Arab Health 2025 aligns with the leadership’s vision, which prioritizes the well-being of society. He highlighted that investing in family health reaffirms the commitment to enhancing quality of life and ensuring a sustainable lifestyle for all members of the Emirati family.
A standout project within this theme is the “Usrati Bundle.” Developed in collaboration with the Federal Authority for Identity, Citizenship, Customs and Port Security, and the Telecommunications and Digital Government Regulatory Authority, the “My Family platform” offers integrated services catering to all stages of family life, from marriage to child education. Among its key services, EHS has launched the “Premarital Genetic Tests,” testing 570 genes to detect potential hereditary diseases and promoting healthy families for future generations.
Additionally, EHS is presenting the “In-Utero Gene Editing” research project in collaboration with the Children’s Hospital of Philadelphia. This project aims to permanently correct genetic mutations at the DNA level during pregnancy or shortly after birth, targeting serious genetic disorders such as ‘Phenylketonuria (PKU)’ and ‘Sickle Cell Anemia’. The project utilizes lipid nanoparticles for gene editing, aiming to improve patients’ quality of life and reduce future suffering.
For the first time, EHS is also introducing an early detection programme for breast cancer using artificial intelligence. Developed in collaboration with the Ministry of Education and the Ministry of Health and Prevention, this programme uses the advanced “Bexa” device for screenings, known for its precision in detecting tumors. The device enhances early detection rates and significantly improves survival outcomes.